Back

Nanoformulated linseed oil differentially modulates ex vivo monocyte inflammation of patients with coronary artery disease: identification of responders and non-responders

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Vascular interventions, thrombosis, and stroke Leukocytes, Inflammation, Immunity ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speakers

Photo
Doctor Sandy Hmadeh

University of Strasbourg, Strasbourg (France)

Photo
Professor Valerie Schini-Kerth

INSERM, University of Strasbourg, CRBS, Strasbourg (France)

6 More presentations in this session

Presentation thumbnail
VASCRAFT: a novel tissue-engineered human vascular graft for coronary artery bypass grafting (CABG)
Miss G. Iraola Picornell (Badalona, Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
AT1a receptors in the subfornical organ increase splenic nerve activity and blood pressure in response to chronic Angiotensin II
Doctor M. Perrotta (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Role and mechanism of xanthine oxidase in platelet hyperreactivity of hyperuricemia patients
Miss W. Gao (Shanghai, CN)
Presentation thumbnail
β-Hydroxybutyrate directly binds to ANXA2 and suppresses AAA progression by inhibiting macrophage infiltration and vascular smooth muscle cell apoptosis
Ms F. Zheng (CN)
Abstract Slides Video
Presentation thumbnail
Recovery from ischemic stroke depends upon a Treg lymphokine-induced meningeal lymphatic growth and drainage
Doctor Y. Bai (Shanghai, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Vascular interventions, thrombosis, and stroke

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Nanoformulated omega-3 rich linseed oil reversed IL-6+TNF-a-induced M1 polarized THP-1 cells and monocytes of healthy donors and the activated monocytes of patients with coronary artery disease
29 August 2025
thumbnail
Congress Presentation
Characterising patients and lesions with plaque progression despite high-intensity LDL-C-lowering therapy: a multimodality serial intracoronary imaging study from the IBIS-4 and PACMAN-AMI trials
28 August 2026
thumbnail
Congress Presentation
A continuum of multifactorial benefits of icosapent ethyl.
26 August 2022
thumbnail
Congress Presentation
Novel histo-proteomic subtyping of coronary atherosclerosis identifies CAPG as a key inflammatory driver in plaque destabilisation
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources